FindTrial
Sign In

Application of preoperative thoracoscopic-guided paravertebral block in the perioperative period of thoracoscopic-laparscopic esophagectomy

Application of preoperative thoracoscopic-guided paravertebral block in the perioperative period of thoracoscopic-laparscopic esophagectomy

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2400091153
Enrollment
Unknown
Registered
2024-10-22
Start date
2023-02-16
Completion date
Unknown
Last updated
2024-10-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

esophageal cancer

Interventions

experiment group:Thoracoscopic guided paravertebral block
Positive control group:Ultrasound guided paravertebral block
Sham group:normal saline

Sponsors

Ningbo Medical Center Lihuili Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
20 Years to 75 Years

Inclusion criteria

Inclusion criteria: Patients aged 20-75 years, classified as American Society of Anesthesiologists (ASA) grade I-III, with preoperative tumor stage I-II, no neurological or muscular disorders, no history of spinal deformities, fractures, injuries, or surgeries, who agree to participate in this study.

Exclusion criteria

Exclusion criteria: Refusal of thoracoscopic surgery, abnormal coagulation function, history of spinal deformities, fractures, trauma or surgery, history of thoracic aortic aneurysm, severe pleural adhesions, unplanned second surgery after surgery, allergies to LAs, failure to block, mismatched or requested withdrawal during the research process.

Design outcomes

Primary

MeasureTime frame
VAS, visual analogue scale;Stress indicators;Inflammatory indicators;Postoperative recovery indicators;—

Countries

China

Contacts

Public ContactLihong Hu

Ningbo Medical Center Lihuili Hospital

hlh_2000@163.com+86 135 8658 4415

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026